BEAM Beam Therapeutics Inc.
Healthcare$29.34+0.00%OpenMarket Cap: $3.02B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$48.00
Target (Median)
$40.00
Target Range
$26.00 - $80.00
Upside from current price: 63.6%
Rating Distribution
1 Strong Buy14 Buy2 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-13 | Bernstein | maintain | Outperform | Outperform |
| 2026-03-26 | Citigroup | maintain | Buy | Buy |
| 2026-02-25 | Wedbush | maintain | Outperform | Outperform |
| 2026-02-25 | RBC Capital | maintain | Sector Perform | Sector Perform |
| 2026-01-21 | Bernstein | maintain | Outperform | Outperform |
| 2025-10-10 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-10-09 | JP Morgan | maintain | Overweight | Overweight |
| 2025-08-06 | Barclays | maintain | Equal Weight | Equal Weight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-4.59 | $78.5M | 11 |
| Sun Dec 31 | $-4.51 | $130.0M | 11 |
| Mon Dec 31 | $-3.01 | $412.5M | 4 |
| Tue Dec 31 | $-0.32 | $907.4M | 4 |